SlidesetHIVViral Hepatitis and Liver DiseaseClinical Pharmacology Long Acting ARVs - Marta Boffito, MD, PhD, FRCPView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEmerging Infections and Biosecurity - Mohammed Lamorde, FRCP, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseFDA Perspectives on COVID-19 Drug Development - Kimberly Struble, PharmaDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseNovel Formulations and Devices - Charles Flexner, MDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseasePerspectives on the Use of Endogenous Bio-markers to Assess Transporter Mediated Drug-Drug Interations_DDIs - Vikram Arya, PhD, FCPView Slideset
SlidesetHIVViral Hepatitis and Liver DiseasePharmacology of bNABs - Edmund Capparelli, PharmaDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseRole of Herbal (and CAMs) in DDIs - Dario Cattaneo, PharmaD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseThe Role of Pharmacology in Selection of COVID-19 Candidates - Andrew Owen, PhD, FRSB, FBPhS, FLSWView Slideset